Athens Medical CentreFRA:ACS +15.46%67 PB Ratio is 1.53 as of Jun. 27, 2026, which is 2% above its 10-year median of 1.50. GuruFocus rates FRA:ACS with a GF Score™ of 67/100 and a GF Value™ of €1.72 (Fairly Valued). The stock has 8 warning signs investors should review. Among 611 Healthcare Providers & Services companies, Athens Medical Centre ranks better than 58.27% on this metric.
Athens Medical Centre SA stock PB Ratio (=1.45) is close to 1-year low of 1.37.
The historical rank and industry rank for Athens Medical Centre's PB Ratio or its related term are showing as below:
FRA:ACS'
s PB Ratio Range Over the Past 10 Years
Min: 0.8 Med: 1.5 Max: 2.83
Current: 1.45
During the past 13 years, Athens Medical Centre's highest PB Ratio was 2.83. The lowest was 0.80. And the median was 1.50.
FRA:ACS's PB Ratio is ranked better than 58.27% of 611
companies
in the Healthcare Providers & Services industry
Industry Median: 1.98
vs FRA:ACS: 1.45
During the past 12 months, Athens Medical Centre's average Book Value Per Share Growth Rate was -4.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 0.20% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 3.30% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 7.40% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Athens Medical Centre was 12.50% per year. The lowest was -23.70% per year. And the median was 1.15% per year.
Back to Basics: PB Ratio
Athens Medical Centre (FRA:ACS) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Athens Medical Centre's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Athens Medical Centre PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Athens Medical Centre's PB Ratio distribution charts can be found below:
* The bar in red indicates where Athens Medical Centre's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Athens Medical Centre (FRA:ACS) has a PB Ratio of 1.53 as of Jun. 27, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Athens Medical Centre and its competitors. This is near median its historical median of 1.50. Over the past decade, Athens Medical Centre's PB Ratio has ranged from 0.80 to 2.83. According to the industry distribution chart, Athens Medical Centre ranks #255 out of 611 companies in the Healthcare Providers & Services industry, placing it in the top 41.7%.
Is Athens Medical Centre's PB Ratio too high?
Athens Medical Centre's current PB Ratio of 1.53 is near median its 10-year median of 1.50. Over the past 10 years, this metric has ranged from a low of 0.80 to a high of 2.83. The Healthcare Providers & Services industry median PB Ratio is 1.98. Athens Medical Centre's value of 1.53 is 22.7% below this industry median. Based on the distribution chart, Athens Medical Centre ranks #255 out of 611 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Athens Medical Centre has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Athens Medical Centre's PB Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Athens Medical Centre ranks #255 out of 611 companies for PB Ratio. This puts Athens Medical Centre in the upper half of its industry. The industry median PB Ratio is 1.98. Athens Medical Centre's value of 1.53 is 22.7% below this benchmark. Historically, Athens Medical Centre's own PB Ratio has ranged from 0.80 to 2.83 over the past decade. While the company's 10-year median is 1.50 vs. the industry median of 1.98, Athens Medical Centre has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.98, based on 611 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Athens Medical Centre's current PB Ratio of 1.53 is 22.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Athens Medical Centre and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Athens Medical Centre's current PB Ratio is 1.53, which is near median its own 10-year median of 1.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Athens Medical Centre stock overvalued right now?
Based on GuruFocus' analysis, Athens Medical Centre (FRA:ACS) is currently considered Fairly Valued. The stock's GF Value™ is €1.72, compared to a current price of €1.83 — trading 6.4% above its estimated fair value. The current PB Ratio is 1.53, which is near median its 10-year median of 1.50 and 22.7% below the Healthcare Providers & Services industry median of 1.98. Athens Medical Centre's overall GF Score™ is 67/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Athens Medical Centre (FRA:ACS), the current PB Ratio is 1.53 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Athens Medical Centre (FRA:ACS) Overvalued in 2026?
Based on GuruFocus' analysis, Athens Medical Centre stock appears to be overvalued.
The current stock price of €1.83 is trading 6.4% above its estimated GF Value™ of €1.72.
GuruFocus considers Athens Medical Centre to be Fairly Valued.
Key valuation signals for FRA:ACS:
PB Ratio: 1.53 (near median its 10-year median of 1.50)
GF Value™: €1.72 vs. price of €1.83 (6.4% above fair value)
Industry Position: 22.7% below the Healthcare Providers & Services median (#255 of 611)
No single metric tells the full story. See the FRA:ACS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Athens Medical Centre SA engages in the provision of healthcare services. It includes medical research and methods of treatment, training, and selection of executives and staff on behalf of the hospitals and importation of medical tools, instruments, machinery, and automated devices for the hospitals. Its offering includes medical services in such specializations as pathology, cardiology, general surgery, plastic and vascular surgery, orthopedic, physiotherapy, ophthalmology, urology, neurosurgery, thoracic, pediatric, dermatology, endocrinology and stomatology. The company operates in Domestic healthcare service, Healthcare service provided abroad (Romania) and Sale of medical tools & sanitary/health equipment segment.
67GF Score
Get the complete analysis for FRA:ACS
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:ACS has been successfully added to your 
